Ian Michael Estepan - 01 Mar 2026 Form 4 Insider Report for Sarepta Therapeutics, Inc. (SRPT)

Signature
/s/ Cristin L. Rothfuss, as Attorney-in-Fact for Ian Michael Estepan
Issuer symbol
SRPT
Transactions as of
01 Mar 2026
Net transactions value
-$67,651
Form type
4
Filing time
03 Mar 2026, 20:04:02 UTC
Previous filing
02 Mar 2026
Next filing
11 Mar 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Estepan Ian Michael Chief Operating Officer 215 FIRST STREET, SUITE 415, CAMBRIDGE /s/ Cristin L. Rothfuss, as Attorney-in-Fact for Ian Michael Estepan 03 Mar 2026 0001836254

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRPT Common Stock Options Exercise +8,125 +4% 208,875 01 Mar 2026 Direct F1
transaction SRPT Common Stock Tax liability $53,476 -3,301 -1.6% $16.20 205,574 02 Mar 2026 Direct F2
transaction SRPT Common Stock Tax liability $14,175 -875 -0.43% $16.20 204,699 02 Mar 2026 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SRPT Performance Stock Units Options Exercise $0 -8,125 -100% $0.000000 0 01 Mar 2026 Common Stock 8,125 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares previously earned under a PSU award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the prescribed milestones under the terms of the PSU award. The shares vested on March 1, 2026.
F2 Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of a PSU award granted on March 1, 2024.
F3 Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 1, 2024.